Cellular therapy reverses myocardial dysfunction

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Cell Therapy

Background:

• Cellular cardiomyoplasty involves implanting autologous skeletal muscle cells into the heart.
• This aims to reinforce myocardial structure and improve cardiac function.
• Developing reproducible methods for creating myocardial lesions is crucial for studying cell implantation efficacy.

Purpose of the Study:

• To develop a reproducible method for creating myocardial lesions using snake cardiotoxin.
• To evaluate the functional benefit of autologous skeletal muscle cell implantation into these lesions.
• To assess both global and regional myocardial contraction post-implantation using echocardiography.

Main Methods:

• A sheep model was used, inducing left ventricular transmural lesions via intramyocardial snake cardiotoxin injection.
• Echocardiography assessed lesion characteristics before cell implantation.
• Autologous skeletal muscle cells or control media were injected; myocardial contraction was re-evaluated after two months, with cell analysis using myosin heavy chain antibody.

Main Results:

• Snake cardiotoxin reliably created well-delineated transmural myocardial lesions in all subjects.
• Echocardiographic analysis revealed significant improvements in global and regional left ventricular function in sheep treated with cell implantation.
• Histological examination confirmed the survival of implanted satellite cells at the lesion periphery.

Conclusions:

• Implanted satellite cells demonstrated survival for up to two months within the cardiotoxin-induced myocardial lesion.
• This cell implantation was associated with significant functional recovery of both local and global myocardial contraction.
• The study supports the potential of cellular cardiomyoplasty for cardiac repair.